Skip to search.
 BSE Down 0.15% NSE Down 0.13%

More On AEZS

Quotes

Charts

News & Info

Company

Analyst Coverage

Ownership

Financials

Aeterna Zentaris Inc. (AEZS)

-NasdaqCM
3.35 0.00(0.00%) 18 Feb 2:30am
Prev Close:3.35
Open:3.45
Bid:2.80 x 1000
Ask:6.50 x 300
1y Target Est:7.67
Beta:0.996441
Next Earnings Date:N/A
Day's Range:3.30 - 3.45
52wk Range:2.35 - 5.59
Volume:113,543
Avg Vol (3m):317,105
Market Cap:43.08M
P/E (ttm):N/A
EPS (ttm):-2.91
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

  • No Headlines available for AEZS at this time.

Comparison

Symbol% ChgMkt Cap
AEZS 0.00%43.08M
CELGUp 2.11%94.26B
1 0.00%N/A

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):55.14
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-16) :-2.38
Quarterly EPS Est (Dec-16) :-0.73
Mean Recommendation*:1.7
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Aeterna Zentaris Inc., a specialty biopharmaceutical company, engages in developing and commercializing novel treatments in oncology, endocrinology, and women's health. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback